Intimation of Closure of Trading Window

Date: 26th September, 2026 Department of Corporate Service (DCS-CRD), BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001. Sub: Intimation for Closure of Trading Window Ref.: Norris Medicines Limited, Scrip Code: 524414 Dear Sir/Madam, This is to inform you that as per the Company’s Code of Conduct for Prohibition of Insider Trading, framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the securities of the Company will be closed with effect from Thursday,1st October, 2026 for the Designated Persons (including, Promoters, Directors, Auditors, Key Managerial Persons & their immediate relatives). The Trading Window will open 48 hours after declaration of Un-audited financial results for the quarter ending 30th September, 2026, made available to the public and submitted with the stock exchange. The date of Board Meeting of the Company for approval of the Un-audited financial results for the quarter ending 30th September, 2026, will be intimated in due course. Accordingly, the Designated Persons (including, Promoters, Directors, Auditors, Key Managerial Persons & their immediate relatives) of the Company have been intimated not to trade (buy/sell/pledge) in the Company's Securities/shares during the closure of Trading Window period as mentioned above. Kindly take the above information on your records. FOR NORRIS MEDICINES LIMITED VIMAL D. SHAH DIRECTOR DIN:01506655